A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies (CaDAnCe-101)
NCT 05006716 Brief Summary Study consists of two main parts to explore…
Read more arrow_forwardNCT 05006716 Brief Summary Study consists of two main parts to explore…
Read more arrow_forwardNCT 04923048 Brief Summary This is a Phase 1/2 study of GB261…
Read more arrow_forwardNCT 06291220 Brief Summary Chronic lymphocytic leukemia (CLL) is the most common…
Read more arrow_forwardNCT 06588478 Brief Summary The main purpose of this study is to…
Read more arrow_forwardNCT 06564038 Brief Summary The purpose of this study is to assess…
Read more arrow_forwardNCT 06846671 Brief Summary The purpose of this study is to investigate…
Read more arrow_forwardNCT 05279300 Brief Summary This is a first-in-human (FIH) study to evaluate…
Read more arrow_forwardNCT 05947851 Brief Summary The purpose of this study is to assess…
Read more arrow_forwardNCT 06542250 Brief Summary This is a Phase I/II study designed to…
Read more arrow_forwardNCT 06697184 Brief Summary The purpose of this study is to establish…
Read more arrow_forward